Business Description
Kbio Co Inc
NAICS : 334290
SIC : 3669
ISIN : KR7038530002
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 14.03 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | 0.7 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.34 | |||||
Beneish M-Score | -1.67 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 31.8 | |||||
3-Year EPS without NRI Growth Rate | -4.6 | |||||
3-Year Book Growth Rate | -15.4 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 65.71 | |||||
9-Day RSI | 56.05 | |||||
14-Day RSI | 50.8 | |||||
3-1 Month Momentum % | -19.1 | |||||
6-1 Month Momentum % | -13.06 | |||||
12-1 Month Momentum % | -14.96 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.99 | |||||
Quick Ratio | 8.32 | |||||
Cash Ratio | 6.4 | |||||
Days Inventory | 30.8 | |||||
Days Sales Outstanding | 35.93 | |||||
Days Payable | 23.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -20.4 | |||||
Shareholder Yield % | 15.34 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 14.4 | |||||
Operating Margin % | -0.77 | |||||
Net Margin % | 2.68 | |||||
FCF Margin % | -3.24 | |||||
ROE % | 2.43 | |||||
ROA % | 1.28 | |||||
ROIC % | -0.61 | |||||
3-Year ROIIC % | 0.79 | |||||
ROC (Joel Greenblatt) % | 37.95 | |||||
ROCE % | 3.28 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.2 | |||||
PE Ratio without NRI | 27.01 | |||||
PS Ratio | 0.47 | |||||
PB Ratio | 0.42 | |||||
Price-to-Tangible-Book | 0.44 | |||||
EV-to-EBIT | -3.9 | |||||
EV-to-EBITDA | -3.13 | |||||
EV-to-Revenue | -0.25 | |||||
EV-to-FCF | 7.78 | |||||
Price-to-GF-Value | 0.41 | |||||
Price-to-Projected-FCF | 0.57 | |||||
Price-to-Median-PS-Value | 0.18 | |||||
Price-to-Graham-Number | 0.73 | |||||
Earnings Yield (Greenblatt) % | -25.64 | |||||
FCF Yield % | -6.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kbio Co Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 58,318.324 | ||
EPS (TTM) (â‚©) | 15.92 | ||
Beta | 1.57 | ||
3-Year Sharpe Ratio | -0.64 | ||
3-Year Sortino Ratio | -0.93 | ||
Volatility % | 47.11 | ||
14-Day RSI | 50.8 | ||
14-Day ATR (â‚©) | 11.796344 | ||
20-Day SMA (â‚©) | 237.25 | ||
12-1 Month Momentum % | -14.96 | ||
52-Week Range (â‚©) | 209 - 453 | ||
Shares Outstanding (Mil) | 115.5 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kbio Co Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kbio Co Inc Stock Events
Event | Date | Price (â‚©) | ||
---|---|---|---|---|
No Event Data |
Kbio Co Inc Frequently Asked Questions
What is Kbio Co Inc(XKRX:038530)'s stock price today?
When is next earnings date of Kbio Co Inc(XKRX:038530)?
Does Kbio Co Inc(XKRX:038530) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |